PathogenDx recently announced that its next-generation cannabis and hemp testing technology, Detectx-Combined, has received an AOAC® Performance Tested Methods SM Certificate to detect Aspergillus species, Salmonella spp. and Shiga toxin-producing Escherichia coli in a single-well test for cannabis matrices. This is the company’s second cannabis testing technology to receive an AOAC Performance Tested Methods SM Certificate to help ensure the quality and safety standards of cannabis, the first being Quantx Fungal One-Step, which is a quantitative molecular test for yeast and mold.

Detectx-Combined is a molecular-based solution that delivers the ability to test for bacterial and fungal species in a single well, which saves time and money spent on lab processing and consumables. PathogenDx states that the use of Detectx-Combined can reduce lab costs by up to 65 percent and provide dual results in six-and-a-half hours. 

By introducing a one-step Loci and Labeling PCR process for bacterial and fungal testing, Detectx-Combined enables labs to increase capacity and throughput. It does not require advanced bioinformatics and can be performed with standard equipment. The solution also reduces assay steps and the chance of manual error.